Brennan Kevin M.

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Xilio Therapeutics Inc (XLO)

Transaction date 2 Jan 2026

Planned sale

Price

241.22

Quantity 90,034 +11.8%

Value US$3,425,246

Comments Filing

Xilio Therapeutics Inc (XLO)

Transaction date 2 Jan 2025

Planned sale

Price

362.02

Quantity 69,662 -46.7%

Value US$3,247,889

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-01-05	2026-01-02	Xilio Therapeutics Inc (XLO)	PlS Planned sale	90,034 +11.8% 241.22 US$3,425,246	90,034 +11.8%	241.22	US$3,425,246
2025-01-03	2025-01-02	Xilio Therapeutics Inc (XLO)	PlS Planned sale	69,662 -46.7% 362.02 US$3,247,889	69,662 -46.7%	362.02	US$3,247,889